Search Results
Overview
| Uniprot ID | P07339 |
|---|---|
| Protein Name | Cathepsin D |
| Gene Name | CTSD |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 122 | IACWIHHKYNSDKSS |
| 127 | HHKYNSDKSSTYVKN |
| 184 | QVFGEATKQPGITFI |
| 253 | MLGGTDSKYYKGSLS |
| 267 | SYLNVTRKAYWQVHL |
| 341 | TLPAITLKLGGKGYK |
| 345 | ITLKLGGKGYKLSPE |
| 348 | KLGGKGYKLSPEDYT |
| 357 | SPEDYTLKVSQAGKT |
Function
Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation (PubMed:27333034). Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0005829 | cytosol |
| Cellular Component | GO:0031904 | endosome lumen |
| Cellular Component | GO:0010008 | endosome membrane |
| Cellular Component | GO:0070062 | extracellular exosome |
| Cellular Component | GO:0031012 | extracellular matrix |
| Cellular Component | GO:0005576 | extracellular region |
| Cellular Component | GO:0005615 | extracellular space |
| Cellular Component | GO:1904813 | ficolin-1-rich granule lumen |
| Cellular Component | GO:0043202 | lysosomal lumen |
| Cellular Component | GO:0005765 | lysosomal membrane |
| Cellular Component | GO:0005764 | lysosome |
| Cellular Component | GO:0042470 | melanosome |
| Cellular Component | GO:0045121 | membrane raft |
| Cellular Component | GO:0035580 | specific granule lumen |
| Cellular Component | GO:1904724 | tertiary granule lumen |
| Molecular Function | GO:0004190 | aspartic-type endopeptidase activity |
| Molecular Function | GO:0070001 | aspartic-type peptidase activity |
| Molecular Function | GO:0004197 | cysteine-type endopeptidase activity |
| Molecular Function | GO:0008233 | peptidase activity |
| Biological Process | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
| Biological Process | GO:0097194 | execution phase of apoptosis |
| Biological Process | GO:1901143 | insulin catabolic process |
| Biological Process | GO:0038020 | insulin receptor recycling |
| Biological Process | GO:0042159 | lipoprotein catabolic process |
| Biological Process | GO:0043065 | positive regulation of apoptotic process |
| Biological Process | GO:0006508 | proteolysis |
| Biological Process | GO:0070201 | regulation of establishment of protein localization |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[2] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.
[3] Shi CM, Wang QC, Li XL, Yang YH, Tang XY et al.. Global Profiling of Protein Lactylation in Human Hippocampi.. Proteomics Clin Appl 19(2):e202400061. 2025 Mar. PMID: 39610256.
[4] He J, Lai T, Zhou Z, Yang H, Lei Z et al.. Multiomics profiling reveals the involvement of protein lactylation in nonhomologous end joining pathway conferring radioresistance in lung adenocarcinoma cell.. Sci Rep 15(1):24651. 2025 Jul 9. PMID: 40634431.